Front. Cell Dev. Biol.Frontiers in Cell and Developmental BiologyFront. Cell Dev. Biol.2296-634XFrontiers Media S.A.10.3389/fcell.2021.770243Cell and Developmental BiologyCorrectionCorrigendum: Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral SclerosisSykovaEva1*CizkovaDasa12*KubinovaSarka31Institute of Neuroimmunology, Slovak Academy of Sciences, Bratislava, Slovakia2Centre for Experimental and Clinical Regenerative Medicine, University of Veterinary Medicine and Pharmacy in Kosice, Kosice, Slovakia3Department of Optical and Biophysical Systems, Institute of Physics of the Czech Academy of Sciences, Prague, Czechia
Edited and reviewed by: Joan Oliva, Emmaus Medical Inc., United States
*Correspondence: Eva Sykova sykovae@gmail.comDasa Cizkova cizkova.dasa@gmail.com
This article was submitted to Stem Cell Research, a section of the journal Frontiers in Cell and Developmental Biology
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
A Corrigendum on Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis by Sykova, E., Cizkova, D., and Kubinova, S. (2021). Front. Cell Dev. Biol. 9:695900. doi: 10.3389/fcell.2021.695900mesenchymal stem cellscell therapyspinal cord injuryamyotrophic lateral sclerosisneurodegenerative diseasesconditioned mediumexosomesbiomaterials
In the original article, there was a mistake in the caption of Figure 2 as published. The description of part (A) was incorrect. The corrected caption appears below.
Figure 2 | Bone marrow mesenchymal stem cells (BMSCs) labeled with iron-oxide nanoparticles implanted into rat with acute balloon-induced spinal cord compression lesion. (A,B) Longitudinal MRI images of spinal cord lesion. (A) At 5 weeks after compression the lesion was detected as a hyperintensive area with a weak hypointense signal. (B) Entire lesion populated by intravenously injected magnetically labeled BMSCs at 4 weeks after implantation is visible as a dark hypointensive area. (C) Prussian blue staining for iron of a spinal cord lesion in control animal. (D) Prussian blue staining for iron of a spinal cord lesion at 4 weeks after labeled BMSCs implantation. Note the smaller lesion size in the animal with implanted BMSC. (E) Prussian blue staining in detail shows a staining for hemoglobin. (F) The lesion is populated with Prussian blue-positive cells. Modified from Jendelová et al. (2004).
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
ReferencesJendelováP.HerynekV.UrdzíkováL.GlogarováK.KroupováJ.AnderssonB.. (2004). Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. J. Neurosci. Res.76, 232–243. 10.1002/jnr.2004115048921